Vimarsana
Biggest News Aggregation in the World

Page 10 - Juniper Point News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Juniper Point. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Juniper Point Today - Breaking & Trending Today

Renibus Therapeutics Announces Participation in Multiple Upcoming Investor Conferences - Vimarsana News

Renibus Therapeutics Announces Participation in Multiple Upcoming Investor Conferences

/PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biotechnology company developing breakthrough products for cardiorenal diseases, today...

PLEXIUM ANNOUNCES APPOINTMENT OF SUZANNE ZOUMARAS AS EXECUTIVE VICE PRESIDENT, HEAD OF HUMAN RESOURCES - Vimarsana News

PLEXIUM ANNOUNCES APPOINTMENT OF SUZANNE ZOUMARAS AS EXECUTIVE VICE PRESIDENT, HEAD OF HUMAN RESOURCES

/PRNewswire/ -- Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the appointment of Suzanne...

Bionano Genomics Announces Launch of CLIA-Certified Bionano Laboratories, and Expands its Clinical Testing Menu with Launch of First OGM-Based LDT for FSHD - Vimarsana News

Bionano Genomics Announces Launch of CLIA-Certified Bionano Laboratories, and Expands its Clinical Testing Menu with Launch of First OGM-Based LDT for FSHD

SAN DIEGO, Sept. 23, 2022 -- Bionano Genomics, Inc. today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome mapping data services with... | September 23, 2022

Jean L. Golden - Vimarsana News

Jean L. Golden

Jean L Golden, 81, of Pittsford, New York, passed away peacefully on Aug.13 with family by her side after obstinately thumbing her nose at cancer for nearly 11 years. Born Jean Virginia Lenhart on February 11, 1941 in Middletown, Connecticut to the...

Myeloid Therapeutics to Participate in September Investor Conferences - Vimarsana News

Myeloid Therapeutics to Participate in September Investor Conferences

/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company harnessing the power of myeloid and innate biology to...